Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05192057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

Study acronym: SALINE
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Oct 1, 2026 → Oct 1, 2027
See other at-risk trials from Radboud University Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2027
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 3 of 13 entries
  2. Primary completion date: May 20, 2026 to Oct 1, 2026
    • Study completion date: Aug 20, 2026 to Oct 1, 2026
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: May 20, 2024 to May 20, 2026
    • Study completion date: Aug 20, 2024 to Aug 20, 2026
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: May 2024 to May 20, 2024
    • Study completion date: May 2024 to Aug 20, 2024
    • Start date changed from estimate of May 10, 2022 to May 20, 2022
    • Site details revised
  2. Start date: Feb 2022 to May 10, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and functional capacities in participants with Mycobacterium avium complex lung disease and compare the effect to treatment with best supportive care alone.
Trial Details
NCT Number NCT05192057
Lead Sponsor Radboud University Medical Center
Conditions
(from sponsor)		 Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex
Related terms Mycobacterium avium-intracellulare Infection
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov